These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 28277805)

  • 1. Intrauterine transfusion and non-invasive treatment options for hemolytic disease of the fetus and newborn - review on current management and outcome.
    Zwiers C; van Kamp I; Oepkes D; Lopriore E
    Expert Rev Hematol; 2017 Apr; 10(4):337-344. PubMed ID: 28277805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postponing Early intrauterine Transfusion with Intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn.
    Zwiers C; van der Bom JG; van Kamp IL; van Geloven N; Lopriore E; Smoleniec J; Devlieger R; Sim PE; Ledingham MA; Tiblad E; Moise KJ; Gloning KP; Kilby MD; Overton TG; Jørgensen DS; Schou KV; Paek B; Walker M; Parry E; Oepkes D; de Haas M
    Am J Obstet Gynecol; 2018 Sep; 219(3):291.e1-291.e9. PubMed ID: 29902448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal intravenous immunoglobulin therapy in rhesus hemolytic disease.
    Kriplani A; Malhotra Singh B; Mandal K
    Gynecol Obstet Invest; 2007; 63(3):176-80. PubMed ID: 17143009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis and perinatal outcome after intravascular transfusion].
    Monico-Ramos R; Ochoa-Flores M; Hernández-Herrera RJ; Flores-Pompa E
    Ginecol Obstet Mex; 2011 Jun; 79(6):351-7. PubMed ID: 21966826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic plasma exchange and intravenous immunoglobulin as primary therapy for D alloimmunization in pregnancy precludes the need for intrauterine transfusion.
    Bellone M; Boctor FN
    Transfusion; 2014 Aug; 54(8):2118-21. PubMed ID: 24673470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrauterine blood transfusion: current indications and associated risks.
    Lindenburg IT; van Kamp IL; Oepkes D
    Fetal Diagn Ther; 2014; 36(4):263-71. PubMed ID: 24903741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic management of fetal anemia: review of standard practice and alternative treatment options.
    Papantoniou N; Sifakis S; Antsaklis A
    J Perinat Med; 2013 Jan; 41(1):71-82. PubMed ID: 23093258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal outcomes of intrauterine transfusion for foetal anaemia due to red blood cell alloimmunisation.
    Şavkli AÖ; Çetin BA; Acar Z; Özköse Z; Behram M; Çaypinar SS; Tayyar A; Yüksel MA
    J Obstet Gynaecol; 2020 Jul; 40(5):649-653. PubMed ID: 31462132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neonatal management and outcome in alloimmune hemolytic disease.
    Ree IMC; Smits-Wintjens VEHJ; van der Bom JG; van Klink JMM; Oepkes D; Lopriore E
    Expert Rev Hematol; 2017 Jul; 10(7):607-616. PubMed ID: 28503958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review.
    Blyth U; Larsson M; Baird A; Waring G; Athiraman N
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10220-10225. PubMed ID: 36121063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and management of fetal anemia due to hemolytic disease.
    van 't Oever RM; Zwiers C; de Winter D; de Haas M; Oepkes D; Lopriore E; Verweij EJJ
    Expert Rev Hematol; 2022 Nov; 15(11):987-998. PubMed ID: 36264850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
    Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
    Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Twenty-four cordocenteses in one woman.
    Ulm B; Ulm MR; Deutinger J; Bernaschek G
    Fetal Diagn Ther; 1999; 14(5):283-5. PubMed ID: 10529571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures.
    Zwiers C; Lindenburg ITM; Klumper FJ; de Haas M; Oepkes D; Van Kamp IL
    Ultrasound Obstet Gynecol; 2017 Aug; 50(2):180-186. PubMed ID: 27706858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.
    de Winter DP; Kaminski A; Tjoa ML; Oepkes D
    BMC Pregnancy Childbirth; 2023 Jan; 23(1):12. PubMed ID: 36611144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting anaemia and transfusion dependency in severe alloimmune haemolytic disease of the fetus and newborn in the first 3 months after birth.
    Ree IMC; de Haas M; Middelburg RA; Zwiers C; Oepkes D; van der Bom JG; Lopriore E
    Br J Haematol; 2019 Aug; 186(4):565-573. PubMed ID: 31140599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China.
    Pan W; Wu H; Chen J; Mo X; Wang H; Fang Q; Li Y; Huang Y
    Front Pediatr; 2023; 11():1157004. PubMed ID: 37124190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation.
    Castleman JS; Moise KJ; Kilby MD
    Br J Haematol; 2021 Feb; 192(3):425-432. PubMed ID: 32794242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of compensatory erythropoiesis in hemolytic disease of the fetus and newborn due to intrauterine transfusions.
    Ree IMC; Lopriore E; Zwiers C; Böhringer S; Janssen MWM; Oepkes D; De Haas M
    Am J Obstet Gynecol; 2020 Jul; 223(1):119.e1-119.e10. PubMed ID: 31978433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of severe fetal anemia by Doppler measurement of middle cerebral artery: are there other benefits than reducing invasive procedures?
    Garabedian C; Vaast P; Behal H; Coulon C; Duahamel A; Thomas D; Rakza T; Subtil D; Houfflin-Debarge V
    Eur J Obstet Gynecol Reprod Biol; 2015 Sep; 192():27-30. PubMed ID: 26142913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.